I have two children in Montessori and agree wholeheartedly with the above.
I would like to emphasize the check for AMS or AMI. Any school can all themselves a Montessori school, so I'd make sure it's at least certified in one of those two (not familiar with SAIS so cannot comment on that).
JS and C++ are killing it on adoption because they had near monopolies for an extended period of time in their respective areas (browser, native higher level language). They are popular despite their obvious (some in hindsight) shortcomings due to lack of alternatives in the same categories.
“Most” vaccines. The reason why they didn’t have to invent “non-sterilizing” as a term just for COVID vaccines, is because some existing vaccines had this same property. The acellular pertussis vaccine (the aP in TDaP) is non-sterilizing for example, yet I bet you never took any issue with it.
Does measles count as a respiratory infection? It causes coughing, is airborne, and infection happens via nasal passages. The intramuscular measles vaccine seems to work pretty well.
> mRNA vaccines tell our cells to make a piece of the “spike protein” that is found on the surface of the SARS-CoV-2 virus. Since only part of the protein is made, it does not harm the vaccine recipient, but it is antigenic and thus stimulates the immune system to make antibodies.
“mRNA vaccines tell our cells to make a piece of the “spike protein” that is found on the surface of the SARS-CoV-2 virus. Since only part of the protein is made, it does not harm the vaccine recipient, but it is antigenic and thus stimulates the immune system to make antibodies.”
More importantly, we now report for the first time that cannabidiol can selectively kill a subset of Gram-negative bacteria that includes the ‘urgent threat’ pathogen Neisseria gonorrhoeae.
It's impossible to be an expert in every field, particularly those as complicated as medicine. Furthermore, you don't have to rely on authority, I linked to an RCT showing it was ineffective.
"Not particularly profitable", which is speculative, is still profitable. I highly doubt any one at Merck is actively working against selling a drug they already manufacture at a profit, but feel free to provide evidence otherwise.
If Ivermectin worked on COVID-19, the manufacturer of Ivermectin that has made no money on vaccines for COVID-19 would probably be pushing it wouldn't they?
There have been some studies that found it effective in vitro, but as noted in other comments, at several times the safe dosage in vivo.
I am looking forward to this upcoming post about why you decided to avoid target date funds. Specifically I am curious how you calculate that target date funds have nearly twice the expense ratio compared to guideline. VFIFX (https://www.google.com/finance?ei=CWOOUpC2CO-bsgfSRw&q=VFIFX) has an expense ratio of 0.16% while guidelines is 0.13%. Cheaper, yes, but not twice as cheap.
Similarly, I’m curious as to what the details of a “slightly less generic” type system entails.